Editas Medicine, Inc. (EDIT)
3.00
-0.11
(-3.54%)
USD |
NASDAQ |
Aug 24, 16:00
3.00
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Total Assets (Quarterly) : 237.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 237.36M |
| March 31, 2026 | 149.34M |
| December 31, 2025 | 186.53M |
| September 30, 2025 | 201.75M |
| June 30, 2025 | 210.58M |
| March 31, 2025 | 263.65M |
| December 31, 2024 | 341.59M |
| September 30, 2024 | 327.57M |
| June 30, 2024 | 384.80M |
| March 31, 2024 | 440.35M |
| December 31, 2023 | 499.15M |
| September 30, 2023 | 504.65M |
| June 30, 2023 | 541.95M |
| March 31, 2023 | 464.10M |
| December 31, 2022 | 514.32M |
| September 30, 2022 | 531.03M |
| June 30, 2022 | 580.83M |
| March 31, 2022 | 623.11M |
| December 31, 2021 | 677.48M |
| September 30, 2021 | 717.02M |
| June 30, 2021 | 755.88M |
| March 31, 2021 | 780.29M |
| Date | Value |
|---|---|
| December 31, 2020 | 572.60M |
| September 30, 2020 | 597.16M |
| June 30, 2020 | 655.48M |
| March 31, 2020 | 466.74M |
| December 31, 2019 | 508.88M |
| September 30, 2019 | 372.36M |
| June 30, 2019 | 355.62M |
| March 31, 2019 | 378.92M |
| December 31, 2018 | 420.39M |
| September 30, 2018 | 387.63M |
| June 30, 2018 | 393.53M |
| March 31, 2018 | 403.98M |
| December 31, 2017 | 373.26M |
| September 30, 2017 | 339.13M |
| June 30, 2017 | 368.85M |
| March 31, 2017 | 395.04M |
| December 31, 2016 | 229.18M |
| September 30, 2016 | 242.15M |
| June 30, 2016 | 249.60M |
| March 31, 2016 | 248.81M |
| December 31, 2015 | 149.36M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Geron Corp. | 519.01M |
| Novavax, Inc. | 955.58M |
| Recursion Pharmaceuticals, Inc. | 1.213B |
| Agenus, Inc. | 172.69M |
| Amgen, Inc. | 95.64B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.08M |
| Shareholders Equity (Quarterly) | 105.28M |
| Debt to Equity Ratio | 0.6768 |
| Current Ratio | 3.186 |
| Net Debt Paydown Yield | -1.61% |